PDCD1 and neoplasm: Other studies also reported mutations and gene variations either directly in immune system-related genes, such as PD-1, PD-L1, IDO, and VEGF, or in tumor suppressor genes such as TSC2 and VHL, along with transcriptional upregulation of oncogenic pathways in patients with HPD [14,29,30].